Maximizing human capital and improving employee engagement and wellness
First written in FY2023. 4 of 6 entries say "Advanced", first in FY2024. Latest entry: FY2026.
The whole theme swung hardest in 2020: 2 of 16 companies on the "Worse" side.
116 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Employee engagement FY2029 80% 69% 70% 71% Diversity in decision-making positions FY2030 40% − 29% 30%」
For human capital KPIs, employee engagement rose to 71% in FY2025 and diversity in decision-making positions rose to 30%. In addition, 1,273 employees at Mitsubishi Chemical applied for voluntary retirement, as measures were advanced to create a leaner and more productive organization. - FY2026-H1AdvancedAnnual report
「For the six-month period ended 30 September, Mitsubishi Chemical Corporation recorded estimated special retirement payments of ¥27,043 million and other related losses of ¥684 million in connection with the decision to implement its Next Stage Support Program.」
Regarding human capital and the review of the talent portfolio, the Group decided to implement Mitsubishi Chemical's Next Stage Support Program and recognized estimated special retirement payments of ¥27,043 million and related losses of ¥684 million. - FY2025ReframedAnnual report
「Metric Target year Target Actual FY2024 actual Employee engagement FY2029 80ppt 70ppt Wellness awareness FY2029 85ppt 78ppt Diversity in decision-making positions FY2030 40% 29%」
Human capital KPIs were reset from the previous FY2025 targets to employee engagement of 80ppt and wellness awareness of 85ppt, both for FY2029, and diversity in decision-making positions of 40% for FY2030, in line with the new medium-term management plan 2029. FY2024 results were disclosed. - FY2025-H1AdvancedAnnual report
「In July 2024, Tanabe Mitsubishi Pharmaceutical announced the implementation of a voluntary retirement program to accelerate the review of its human resources portfolio, aimed at placing personnel with the capabilities required to execute its growth strategy and creating an organization where highly specialized and diverse employees can thrive, as it seeks to become a company that grows in global markets.」
As a human capital initiative, 田辺三菱製薬 specified a review of its talent portfolio and a voluntary retirement program, with the aim of creating an organization with the staffing, expertise and diversity required for its growth strategy. - FY2024AdvancedAnnual report
「Metric FY2025 target FY2022 actual FY2023 actual Employee engagement 80% 68% 69% Diversity in management 40% 24% 30% Wellness awareness 85% 77% 78%」
The FY2023 results for human capital KPIs were updated to employee engagement of 69%, diversity in management of 30% and wellness awareness of 78%. The disclosure also stated that 408 people participated in career design workshops, 15 people participated in overseas development programs, and the human resources platform system began operating at more than 80% of consolidated subsidiaries. - FY2023First statedAnnual report
「For the Group, people are the source of value creation and the driving force behind both corporate growth and the realization of its Purpose.」
Human capital was positioned as a driving force for realizing the Purpose and achieving growth, and 6 initiatives were organized into a framework: developing next-generation leaders, transforming corporate culture, DE&I, creating a supportive work environment, integrated global operations and human resources governance. Targets for FY2025 were set at employee engagement of 80%, diversity in management of 40% and wellness awareness of 85%, while FY2022 results of 68%, 24% and 77%, respectively, were disclosed.